Monitoring bone density in hypogonadal men by quantitative phalangeal ultrasound

被引:29
|
作者
Zitzmann, M
Brune, M
Vieth, V
Nieschlag, E
机构
[1] Univ Munster, Inst Reprod Med, D-48129 Munster, Germany
[2] Univ Munster, Inst Clin Radiol, D-48129 Munster, Germany
关键词
male hypogonadism; bone density; ultrasound; testosterone;
D O I
10.1016/S8756-3282(02)00831-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monitoring bone density (BMD) in hypoganadal and testosterone (T) substituted men is a major component of andrological therapy and is performed by methods that are cost-intensive and use radiation, such as quantitative computer tomography (QCT). Therefore, we assessed the feasibility of a more practical and inexpensive approach through application of phalangeal quantitative ultrasound (pQUS; IGEA DBM BP Sonic 1200, Sensweiler, Germany) in a cross-sectional study of 521 men, aged 18-91 years (224 healthy controls, 156 newly diagnosed hypogonadal, and 141 T substituted men). The method was compared with QCT of the lumbar spine in the first 80 patients, We evaluated longitudinal changes of amplitude-dependent speed-of-sound (AdSoS) in 54 hypogonadal men from the beginning of T substitution. AdSoS decreased with age (p < 0.0001) and with declining total T concentration with a four to fivefold larger reduction in AdSoS for each nanomole-per-liter decrement in total T in the hypogonadal range (<12 nmol/L) compared with the eugonadal range (p < 0.0001). AdSoS was higher in eugonadal and substituted men than in hypogonadal Patients (P < 0.0001, by analysis of covariance [ANCOVA]). Substituted men <50 years of age showed lower AdSoS than eugonadal men (p = 0.004) and untreated men with secondary hypogonadism had lower values than men with primary hypogonadism (p = 0.005). Therapeutic effects were seen regardless of age, diagnosis, or T substitution modality. In the longitudinal approach. AdSoS increased from 1986 +/- 93 to 2035 +/- 77 m/sec over 237 +/- 57 days with the highest gain in those men with initially the lowest values (p < 0.0001, by ANCOVA for repeated measurements). In comparison to QCT, patients with a lumbar content of hydroxylapatite of <100 mg/cm(3) were reliably identified by pQUS (cutoff level 1965 m/sec, T score -3.5 based on eugonadal subjects; receiver operating characteristics: area under the curve [AUC] 0.94, sensitivity 94.1, specificity 92%,p < 0.0001), but specific values of lumbar MID could not be predicted by pQUS. pQUS represents a feasible, sensitive, and inexpensive method for assessing bone tissue in hypogonadal men over the full age range and also for monitoring the effects of T substitution. (C) 2002 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:422 / 429
页数:8
相关论文
共 50 条
  • [21] Low vitamin K status is associated with low bone mineral density and quantitative ultrasound in men
    Booth, SL
    Broe, KE
    McLean, RR
    Gagnon, DR
    Peterson, JW
    Hannan, MT
    Cupples, LA
    Cheng, DM
    Wilson, PWF
    Dawson-Hughes, B
    Kiel, DP
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S200 - S200
  • [22] A comparison of bone loss in early and late rheumatoid arthritis using quantitative phalangeal ultrasound
    Birkett, V
    Ring, EFJ
    Elvins, DM
    Taylor, G
    Bhalla, AK
    CLINICAL RHEUMATOLOGY, 2003, 22 (03) : 203 - 207
  • [23] A comparison of bone loss in early and late rheumatoid arthritis using quantitative phalangeal ultrasound
    V. Birkett
    E.F.J. Ring
    D.M. Elvins
    G. Taylor
    A.K. Bhalla
    Clinical Rheumatology, 2003, 22 : 203 - 207
  • [24] Bone alterations in children and young adults with renal transplant assessed by phalangeal quantitative ultrasound
    Mussa, Alessandro
    Porta, Francesco
    Gianoglio, Bruno
    Gaido, Maurizio
    Nicolosi, Mario Guido
    De Terlizzi, Francesca
    de Sanctis, Carlo
    Coppo, Rosanna
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (03) : 441 - 449
  • [25] Bone mineral density and bone markers in hypogonadotropic and hypergonadotropic hypogonadal men after prolonged testosterone treatment
    De Rosa, M
    Paesano, L
    Nuzzo, V
    Zarrilli, S
    Del Puente, A
    Oriente, P
    Lupoli, G
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2001, 24 (04) : 246 - 252
  • [26] Bone mineral density and bone markers in hypogonadotropic and hypergonadotropic hypogonadal men after prolonged testosterone treatment
    Michele De Rosa
    L. Paesano
    V. Nuzzo
    S. Zarrilli
    A. Del Puente
    P. Oriente
    G. Lupoli
    Journal of Endocrinological Investigation, 2001, 24 : 246 - 252
  • [27] Long-term effect of testosterone therapy on bone mineral density in hypogonadal men
    Behre, HM
    Kliesch, S
    Leifke, E
    Link, TM
    Nieschlag, E
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (08): : 2386 - 2390
  • [28] Effects of Testosterone Treatment on Bone Mineral Density in Hypogonadal Men Receiving Intrathecal Opioids
    Finch, Philip M.
    Price, Leanne M.
    Pullan, Peter T.
    Drummond, Peter D.
    PAIN PRACTICE, 2015, 15 (04) : 308 - 313
  • [29] Usefulness of bone quantitative ultrasound in management of osteoporosis in men
    Montagnani, A
    Gonnelli, S
    Cepollaro, C
    Mangeri, M
    Monaco, R
    Gennari, L
    Gennari, C
    JOURNAL OF CLINICAL DENSITOMETRY, 2001, 4 (03) : 231 - 237
  • [30] Hypogonadal Men with Higher Body Mass Index have Higher Bone Density and Better Bone Quality but Reduced Muscle Density
    Lina E. Aguirre
    Georgia Colleluori
    Richard Dorin
    David Robbins
    Rui Chen
    Bryan Jiang
    Clifford Qualls
    Dennis T. Villareal
    Reina Armamento-Villareal
    Calcified Tissue International, 2017, 101 : 602 - 611